Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar pbk100 (29.50) Submitted: 6/8/2011 12:01:45 PM : Outperform Start Price: $36.22 MRX Score: -0.45

Magic Formula + Insider buying

Featured Broker Partners


Advertisement